Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Unipro's output in the first half increased by 4.4%

7/26/23 UPRO

En+ Group reported for 6 months of 2023 by RAS

7/26/23 ENPG

TGC-1 reported for 6 months of 2023 by RAS

7/26/23 TGKA

Polyus has collected applications for participation in the repurchase of shares

7/26/23 PLZL

Magnit shareholders agreed to sell to the company 21.5% of its shares

7/26/23 MGNT

Mordovenergosbyt reported for 6 months of 2023

7/26/23 MRSB

Boeing has reported for 6 months of 2023

7/26/23 BA

AT&T reported for 6 months of 2023

7/26/23 T

Saratovenergo reported for 6 months of 2023 by RAS

7/26/23 SARE

General Dynamics reported for 6 months of 2023

7/26/23 GD